Wire Stories
-
573CORRECTING and REPLACING IASO Receives NMPA Acceptance of its First Indication IND Application for CT120, a Fully Human CD19/CD22 Dual-Targeting CAR-T Therapy
PLEASANTON, Calif. & NANJING, China–(BUSINESS WIRE)–#Biopharmaceutical–First sentence of release should read: “…has been accepted by the China National Medical Products Administration (NMPA)…”...
-
621
CORRECTING and REPLACING�RIT and SPIE Partner on 2021 Photonics for Quantum Event
The program, now in its third year, focuses on how photonic devices are impacting quantum science, technology, and applications BELLINGHAM, Wash.–(BUSINESS WIRE)–In...
-
521
Asia Pharmaceutical Directory 2021: Information on 10,000 Pharmaceutical and Biotechnology Companies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Asian Pharmaceutical Directory 2021” directory has been added to ResearchAndMarkets.com’s offering. Keep up to date with the Asian Pharmaceutical Industry...
-
615
AM Best Affirms Credit Ratings of Consumer Insurance Services Limited
SINGAPORE–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of �bbb-� (Good) of...
-
617
AM Best Affirms Credit Ratings of Consumer Insurance Services Limited
SINGAPORE–(BUSINESS WIRE)–AM Best has affirmed the Financial Strength Rating of B+ (Good) and the Long-Term Issuer Credit Rating of �bbb-� (Good) of...
-
610
Options Launch Market-Leading PTP Compliance Reporting Tool, Tempus
LONDON & NEW YORK & HONG KONG–(BUSINESS WIRE)–Options, the leading provider of managed trading infrastructure to the global Capital Markets, today announced...
-
625
IASO Receives NMPA Acceptance of its First Indication IND Application for CT120, a Fully Human CD19/CD22 Dual-Targeting CAR-T Therapy
PLEASANTON, Calif. & NANJING, China–(BUSINESS WIRE)–#Biopharmaceutical—IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell...
-
702
Guangzhou Bio-Gene Announces Oral Presentation at the 2021 ASCO Annual Meeting
GUANGZHOU, China–(BUSINESS WIRE)–Guangzhou Bio-Gene, a clinical-stage biopharmaceutical company developing a pipeline of innovative oncology therapies, today announced the company will present at...
-
662
Blaize Expands Asia-Pacific Distribution in Automotive, Retail, Metro and Industrial Markets via Partnership with Weikeng
Weikeng Group, a multi-billion operation with broad-based diversified customer base to distribute Blaize products in China, Taiwan, and Southeast Asia EL DORADO...
-
576
One Concern and SOMPO Expand Partnership to Develop Global Resilience Market With More Than $100 Million in Total Commitments by SOMPO
MENLO PARK, Calif.–(BUSINESS WIRE)–#AI–One Concern, Inc., today announced that SOMPO Holdings, Inc., has agreed to launch the next phase of their strategic...
